SurgePays Valuation

Is SURG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SURG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SURG ($1.56) is trading below our estimate of fair value ($145.13)

Significantly Below Fair Value: SURG is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for SURG?

Key metric: As SURG is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SURG. This is calculated by dividing SURG's market cap by their current revenue.
What is SURG's PS Ratio?
PS Ratio0.4x
SalesUS$83.60m
Market CapUS$30.60m

Price to Sales Ratio vs Peers

How does SURG's PS Ratio compare to its peers?

The above table shows the PS ratio for SURG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.1x
KORE KORE Group Holdings
0.1x4.6%US$35.6m
UCL uCloudlink Group
0.5x22.6%US$48.7m
KTEL KonaTel
0.5xn/aUS$10.3m
FNGR FingerMotion
3.3xn/aUS$106.5m
SURG SurgePays
0.4x30.1%US$30.6m

Price-To-Sales vs Peers: SURG is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (1.1x).


Price to Sales Ratio vs Industry

How does SURG's PS Ratio compare vs other companies in the US Wireless Telecom Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
KORE KORE Group Holdings
0.1x4.6%US$35.64m
TIOG Tingo Group
0.0005xn/aUS$1.01m
No more companies available in this PS range
SURG 0.4xIndustry Avg. 1.3xNo. of Companies3PS00.81.62.43.24+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: SURG is good value based on its Price-To-Sales Ratio (0.4x) compared to the Global Wireless Telecom industry average (1.3x).


Price to Sales Ratio vs Fair Ratio

What is SURG's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SURG PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.4x
Fair PS Ratio0.9x

Price-To-Sales vs Fair Ratio: SURG is good value based on its Price-To-Sales Ratio (0.4x) compared to the estimated Fair Price-To-Sales Ratio (0.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SURG forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$1.56
US$6.00
+284.6%
50.0%US$9.00US$3.00n/a2
Nov ’25US$1.60
US$5.50
+243.8%
63.6%US$9.00US$2.00n/a2
Oct ’25US$1.79
US$5.50
+207.3%
63.6%US$9.00US$2.00n/a2
Sep ’25US$1.64
US$5.75
+250.6%
65.2%US$9.50US$2.00n/a2
Aug ’25US$2.72
US$6.75
+148.2%
40.7%US$9.50US$4.00n/a2
Jul ’25US$3.10
US$6.75
+117.7%
40.7%US$9.50US$4.00n/a2
Jun ’25US$3.66
US$7.00
+91.3%
42.9%US$10.00US$4.00n/a2
May ’25US$3.69
US$7.00
+89.7%
42.9%US$10.00US$4.00n/a2
Mar ’25US$7.60
US$13.25
+74.3%
13.2%US$15.00US$11.50n/a2
Feb ’25US$7.34
US$13.25
+80.5%
13.2%US$15.00US$11.50n/a2
Jan ’25US$6.45
US$13.25
+105.4%
13.2%US$15.00US$11.50n/a2
Dec ’24US$6.76
US$13.00
+92.3%
15.4%US$15.00US$11.00n/a2
Nov ’24US$4.47
US$13.00
+190.8%
15.4%US$15.00US$11.00US$1.602
Oct ’24US$4.68
US$13.00
+177.8%
15.4%US$15.00US$11.00US$1.792
Sep ’24US$5.17
US$13.00
+151.5%
15.4%US$15.00US$11.00US$1.642
Aug ’24US$5.58
US$12.75
+128.5%
17.6%US$15.00US$10.50US$2.722
Jul ’24US$7.31
US$12.75
+74.4%
17.6%US$15.00US$10.50US$3.102
Jun ’24US$7.30
US$12.75
+74.7%
17.6%US$15.00US$10.50US$3.662
May ’24US$4.25
US$12.25
+188.2%
22.4%US$15.00US$9.50US$3.692
Apr ’24US$4.49
US$12.00
+167.3%
25.0%US$15.00US$9.00US$3.932
Mar ’24US$5.64
US$12.00
+112.8%
25.0%US$15.00US$9.00US$7.602
Feb ’24US$6.00
US$12.00
+100.0%
25.0%US$15.00US$9.00US$7.342
Jan ’24US$6.56
US$12.00
+82.9%
25.0%US$15.00US$9.00US$6.452
Dec ’23US$7.14
US$12.00
+68.1%
25.0%US$15.00US$9.00US$6.762
Nov ’23US$5.70
US$9.38
+64.5%
6.7%US$10.00US$8.75US$4.472

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies